Introduction

Philadelphia Eagles quarterback Jalen Hurts has been diagnosed with a serious blood clot condition that will end his 2026 season. After initial concerns surfaced during the team's London game, further testing revealed the clots had moved from his calf to his lungs, prompting the Eagles to place him on injured reserve.

What Happened

Hurts first sought treatment for a calf injury following the Eagles' game against the Rams. After undergoing screening in London, doctors initially diagnosed him with superficial vein thrombosis, clearing him to play against Jacksonville. However, a follow-up ultrasound after returning to Philadelphia revealed the clot had traveled up his bloodstream. Philadelphia subsequently announced he would miss Week 6 against the Panthers.

On October 19, the Eagles confirmed Hurts had been diagnosed with deep vein thrombosis and bilateral pulmonary emboli. The blood clots had moved into his lungs, and he was ruled out for the remainder of the year. The organization stated his prognosis is good and he is expected to make a full recovery once off blood-thinning medication.

Why This Matters

The situation has drawn significant attention to how the Eagles managed Hurts' condition, particularly the decision to allow him to fly internationally after a blood clot was discovered. Critics and fans alike have questioned whether the team's handling prioritized player safety. The case also highlights the risks athletes face with venous thromboembolism and the importance of thorough medical screening in professional sports.

Key Takeaways

  • Jalen Hurts has been diagnosed with deep vein thrombosis and bilateral pulmonary emboli, ending his 2026 season.
  • The blood clots migrated from his left calf to his lungs, requiring immediate medical intervention.
  • The Eagles placed Hurts on injured reserve and outlined a treatment plan involving blood thinners.
  • Team statements emphasize that his long-term health outlook is positive with no expected lasting effects.
  • The timeline spans from initial calf treatment in early October to the season-ending diagnosis in mid-October.

Conclusion

Jalen Hurts' blood clot diagnosis marks a significant and concerning development for the Eagles and their fanbase. While the organization expresses confidence in his full recovery, the incident underscores the critical need for vigilant medical monitoring in high-contact sports. Hurts will spend the offseason focusing on recovery, with the goal of returning to full contact activity once his treatment course is complete.